Cencora (COR) Gains from Investment Securities (2009 - 2026)
Cencora (COR) reported Gains from Investment Securities of -$210.0 million for Q1 2026, down 632.14% on a YoY basis from $39.5 million in Q1 2025, and down 170.79% quarter-over-quarter from -$77.6 million in Q4 2025.
Cencora (COR) Gains from Investment Securities (2009 - 2026) Analysis & Trends
Cencora has reported Gains from Investment Securities for 18 years, with the latest figure at -$210.0 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 632.14% year-over-year to -$210.0 million; the trailing twelve-month figure through Mar 2026 stood at -$320.0 million (down 934.92% YoY), and the FY2025 full-year result was -$76.9 million, down 298.77% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$210.0 million, down from -$77.6 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $54.3 million in Q1 2023, with the low at -$210.0 million in Q1 2026.
- Historically, Gains from Investment Securities has averaged -$17.0 million across 5 years, with a median of -$14.0 million in 2023.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities jumped 437.94% — and 2025, when it sank 861.19%.
- Cencora's Gains from Investment Securities stood at -$2.7 million in 2022, then sank by 419.12% to -$14.0 million in 2023, then surged by 180.85% to $11.3 million in 2024, then tumbled by 786.21% to -$77.6 million in 2025, then tumbled by 170.79% to -$210.0 million in 2026.
- The last three Gains from Investment Securities figures came in at -$210.0 million (Q1 2026), -$77.6 million (Q4 2025), and $19.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -210.03 Mn |
| Mar 31, 2026 | -210.03 Mn |
| Dec 31, 2025 | -77.56 Mn |
| Dec 31, 2025 | -77.56 Mn |
| Sep 30, 2025 | 19.60 Mn |
| Sep 30, 2025 | 19.60 Mn |
| Jun 30, 2025 | -52.06 Mn |
| Jun 30, 2025 | -52.06 Mn |
| Mar 31, 2025 | 39.47 Mn |
| Mar 31, 2025 | 39.47 Mn |
| Dec 31, 2024 | 11.30 Mn |
| Dec 31, 2024 | 11.30 Mn |
| Sep 30, 2024 | -19.28 Mn |
| Sep 30, 2024 | -19.28 Mn |
| Jun 30, 2024 | 6.84 Mn |
| Jun 30, 2024 | 6.84 Mn |
| Mar 31, 2024 | -22.84 Mn |
| Mar 31, 2024 | -22.84 Mn |
| Dec 31, 2023 | -13.98 Mn |
| Dec 31, 2023 | -13.98 Mn |